The Downtrend of CTI Biopharma Corp (Nasdaq:CTIC) Still Hard to Break
[[tagnumber 0]][[tagnumber 1]]CTI Biopharma Corp (Nasdaq:CTIC) seems to be following the well–paved path of a typical biopharmaceutical company. With a fully–marketable drug for sale in a few European countries and a leading product candidate...